These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11022181

  • 21. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 22. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
    De Leo V, la Marca A, Lanzetta D, Cariello PL, D'Antona D, Morgante G.
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
    [Abstract] [Full Text] [Related]

  • 23. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.
    Ditkoff EC, Fruzzetti F, Chang L, Stancyzk FZ, Lobo RA.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):603-7. PubMed ID: 7852527
    [Abstract] [Full Text] [Related]

  • 24. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 25. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C, Reyna R, Boots LS, Azziz R.
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [Abstract] [Full Text] [Related]

  • 26. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
    Liu DM, Torchen LC, Sung Y, Paparodis R, Legro RS, Grebe SK, Singh RJ, Taylor RL, Dunaif A.
    Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708
    [Abstract] [Full Text] [Related]

  • 27. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP, Hatziioanidis AH, Trovas GP, Misichronis GS, Kounadi TG, Devetzaki OA, Andronis CK, Rangou DB, Chlouverakis CS.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [Abstract] [Full Text] [Related]

  • 28. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV, Lobo RA.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [Abstract] [Full Text] [Related]

  • 29. Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome.
    Hendriks ML, Ket JC, Hompes PG, Homburg R, Lambalk CB.
    Hum Reprod Update; 2007 Mar; 13(3):249-64. PubMed ID: 17208949
    [Abstract] [Full Text] [Related]

  • 30. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E, Kunicki M, Radowicki S.
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [Abstract] [Full Text] [Related]

  • 31. Response of the pituitary-adrenal axis to hypoglycemic stress in women with the polycystic ovary syndrome.
    Gennarelli G, Holte J, Stridsberg M, Lundqvist U, Massobrio M, Bäckström T, Berne C.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):76-81. PubMed ID: 9920065
    [Abstract] [Full Text] [Related]

  • 32. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

  • 33. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.
    Rosenfield RL, Mortensen M, Wroblewski K, Littlejohn E, Ehrmann DA.
    Hum Reprod; 2011 Nov; 26(11):3138-46. PubMed ID: 21908468
    [Abstract] [Full Text] [Related]

  • 34. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K, Takahashi K, Eda Y, Okada S, Kitao M.
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [Abstract] [Full Text] [Related]

  • 35. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL, Rigg LA, Anderson DC, Yen SS.
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [Abstract] [Full Text] [Related]

  • 36. Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.
    Gonzalez F, Chang L, Horab T, Lobo RA.
    Fertil Steril; 1996 Sep; 66(3):354-61. PubMed ID: 8751729
    [Abstract] [Full Text] [Related]

  • 37. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K, Keleştimur F, Bayram F, Sahin Y, Tutuş A.
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [Abstract] [Full Text] [Related]

  • 38. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
    Guido M, Romualdi D, Suriano R, Giuliani M, Costantini B, Apa R, Lanzone A.
    Hum Reprod; 2004 Mar; 19(3):534-9. PubMed ID: 14998947
    [Abstract] [Full Text] [Related]

  • 39. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM, Taylor AE, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [Abstract] [Full Text] [Related]

  • 40. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
    Medina M, Herrera J, Flores M, Martin O, Bermúdez JA, Zárate A.
    Fertil Steril; 1986 Dec; 46(6):1021-5. PubMed ID: 3023147
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.